or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed ...

GSK has reached ... 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed to pay $2.2 billion to settle ...

UK pharmaceutical giant GSK says ... have both agreed to settle cases. Boehringer Ingelheim is the exception. It has not announced any major settlements. A drug under the name of Zantac 360 ...

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that ... in the summer of 2022 after concerns about ...

The three-day hearing comes a few months after GSK decided to settle a complaint brought ... The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N ...

GSK’s shares ... slightly lower after it agreed a $2.2 billion settlement over lawsuits in the US, which alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer.

To apply for a cash advance lawsuit loan from your anticipated GSK Zantac lawsuit settlement, please visit the company's website HERE or call 877.571.0405. There is no way to estimate final ...

2023 GSK Settles Another California Lawsuit on Heartburn Drug Zantac GSK on Wednesday said it agreed to settle another lawsuit in California alleging its discontinued heartburn drug Zantac caused ...

Reuters Health Information, October 09, 2024 GSK Agrees to Settle About 80,000 Zantac Lawsuits for Up to $2.2 Billion GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state ...